Tanvex BioPharma USA, Inc. announced that it expects to receive $55 million in funding from Tanvex BioPharma, Inc.

Tanvex BioPharma USA, Inc. announced that it will raise $55 million in a round of funding on February 24, 2023. The transaction will include participation from returning investor, Tanvex BioPharma, Inc. The company will issue common shares in the transaction. The transaction has been approved at the board of directors of the company.